Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.33
+$0.32 (+4.00%)
Nov 2, 2026, 10:39 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 630K | 516K | 1.6M | 3.45M | 17.58M | 98.15M | 32.75M | 40.19M | 28.64M | 27.36M | 4.25M | 2.14M | 957K | 1.23M | 221K | 4.46M | 51.58M | 7.31M | 7.55M | 5.37M | 3.87M | 3.55M |
Cost of Revenue | 191K | 124K | 104K | 115K | 554K | 20.44M | 6.8M | 7.6M | 4.63M | 1.99M | 3.16M | 2.62M | 2.9M | 216K | 59.97M | n/a | n/a | 74.96M | 79.13M | n/a | 68.48M | 64.06M |
Gross Profit | 439K | 392K | 1.49M | 3.34M | 17.02M | 77.71M | 25.96M | 32.59M | 24.01M | 25.37M | 1.09M | -477K | -1.94M | 1.01M | -59.75M | 4.46M | 51.58M | -67.65M | -71.59M | 5.37M | -64.61M | -60.51M |
Operating Income | -4.72M | -3.37M | -2.56M | -3.57M | 3.2M | 38.8M | -12.2M | -21.76M | -18.23M | -31.25M | -53.28M | -69.61M | -71.41M | -75.02M | -75.54M | -84.62M | -32.13M | -88.22M | -93.4M | -84.81M | -84M | -78.25M |
Interest Income | 78K | 54K | 100K | 204K | 143K | 236K | 597K | 459K | 450K | 604K | 711K | 1.22M | 1.7M | 1.8M | n/a | 973K | 704K | 228K | 84K | 148K | 225K | n/a |
Pretax Income | -4.83M | -4.15M | -3.41M | -4.28M | 2.39M | 38.01M | -12.71M | -21.93M | -19.05M | -31.73M | -60.44M | -69.82M | -71.11M | -74.75M | -74.57M | -84.08M | 18.47M | -88.11M | -93.32M | -84.66M | -83.78M | -78.34M |
Net Income | -4.83M | -4.15M | -3.41M | -4.3M | 2.39M | 38.01M | -12.69M | -21.91M | -19.05M | -31.75M | -60.45M | -69.8M | -71.11M | -74.77M | -74.57M | -84.09M | 18.47M | -88.11M | -93.35M | -84.66M | -83.79M | -78.34M |
Selling & General & Admin | 3.81M | 3.6M | 4.28M | 3.99M | 5.94M | 11.48M | 9.44M | 10.42M | 8.91M | 11.11M | 10.39M | 12.25M | 13.34M | 13.87M | 9.83M | 18.92M | 18.81M | 20.57M | 21.82M | 19.85M | 19.4M | 17.74M |
Research & Development | 1.35M | 164K | -223K | 2.93M | 7.31M | 27.43M | 28.72M | 43.92M | 33.33M | 45.51M | 43.98M | 56.89M | 56.14M | 62.16M | 62.52M | 70.16M | 64.9M | 74.96M | 79.13M | 70.33M | 68.48M | 64.06M |
Other Expenses | n/a | n/a | n/a | n/a | 579K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -56.55M | n/a | n/a | -74.96M | -79.13M | n/a | -68.48M | -64.06M |
Operating Expenses | 5.16M | 3.76M | 4.05M | 6.91M | 13.82M | 38.91M | 38.16M | 54.35M | 42.24M | 56.62M | 54.37M | 69.14M | 69.48M | 76.03M | 15.79M | 89.08M | 83.71M | 20.57M | 21.82M | 90.18M | 19.4M | 17.74M |
Interest Expense | 191K | 830K | 894K | 909K | 972K | 1.02M | 1.02M | 1.18M | 1.26M | 1.15M | 1.18M | 1.4M | 1.38M | 1.34M | n/a | 123K | 129K | 4K | n/a | n/a | n/a | 90K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.35M | 3.89M | 4.16M | 7.03M | 14.38M | 59.35M | 44.96M | 61.95M | 46.87M | 58.6M | 57.53M | 71.75M | 72.37M | 76.24M | 75.76M | 89.08M | 83.71M | 95.53M | 100.95M | 90.18M | 87.87M | 81.8M |
Income Tax Expense | 1K | n/a | n/a | 28K | 3K | n/a | -19K | -17K | n/a | 24K | 11K | -19K | 1K | 22K | 2K | 10K | n/a | n/a | 30K | n/a | 16K | n/a |
Shares Outstanding (Basic) | 15.03M | 14.08M | 12.54M | 13.56M | 12.2M | 10.76M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.68M | 3.66M |
Shares Outstanding (Diluted) | 15.03M | 14.08M | 12.72M | 13.56M | 12.31M | 10.85M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.69M | 3.66M |
EPS (Basic) | -0.32 | -0.29 | -0.25 | -0.32 | 0.20 | 3.53 | -1.19 | -2.93 | -3.10 | -5.65 | -13.98 | -16.40 | -16.91 | -17.98 | -18.07 | -20.53 | 4.50 | -21.87 | -23.96 | -22.61 | -22.73 | -21.41 |
EPS (Diluted) | -0.32 | -0.29 | -0.25 | -0.32 | 0.19 | 3.50 | -1.19 | -2.93 | -3.10 | -5.65 | -13.98 | -16.40 | -16.91 | -17.98 | -18.07 | -20.53 | 4.50 | -21.87 | -23.96 | -22.61 | -22.75 | -21.41 |
EBITDA | -4.57M | -3.29M | -2.46M | -3.33M | 3.6M | 40.82M | -10.6M | -19.51M | -16.46M | -29.18M | -58.06M | -67.21M | -68.53M | -72.2M | -68.32M | -82.59M | 20.03M | -86.51M | -90.9M | -82.35M | -81.44M | -76M |
EBIT | -4.64M | -3.32M | -2.51M | -3.37M | 3.36M | 39.03M | -11.7M | -20.74M | -17.79M | -30.58M | -59.26M | -68.42M | -69.73M | -73.41M | -69.58M | -83.96M | 18.6M | -88.1M | -93.32M | -84.66M | -83.78M | -78.25M |
Depreciation & Amortization | 72K | 29K | 49K | 36K | 236K | 1.8M | 1.1M | 1.23M | 1.33M | 1.39M | 1.21M | 1.21M | 1.2M | 1.21M | 1.26M | 1.37M | 1.44M | 1.59M | 2.42M | 2.32M | 2.34M | 2.24M |
Add to Watchlist
Select watchlists to add or remove ATRA